## ITW: Illinois Tool Works Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 0.7% below STRENGTH zone (3.0-6.0%); PEG 3.56 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.4% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($242.66)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 0, Bearish: 4)

**1. Illinois Tool Works (ITW) was downgraded to a Sell Rating at Goldman Sachs**
- Source: The Globe and Mail | 20251217T140836 | Bearish | Relevance: 100%
- Goldman Sachs analyst Joe Ritchie downgraded Illinois Tool Works (ITW) to a Sell rating and issued a price target. This downgrade follows a similar Sell rating from Wells Fargo, though Citi maintained a Hold rating on the stock earlier. The company reported a quarterly revenue of $4.06 billion and a net profit of $821 million for the quarter ending September 30, with insider sentiment showing an increase in buying activity.

**2. ITW (NYSE: ITW) makes Multimatic 215 PRO welder available for MIG, TIG, stick**
- Source: Stock Titan | 20251216T153217 | Somewhat-Bullish | Relevance: 100%
- Miller Electric Mfg. LLC, a subsidiary of Illinois Tool Works Inc. (NYSE: ITW), has officially launched the Multimatic 215 PRO multiprocess welder. This advanced welder offers versatility for MIG, DC TIG, and stick welding, along with features like USB-enabled upgrades, a higher duty cycle, and simplified setup via an intuitive color display. Designed for professionals and small to midsized operations, it aims to enhance productivity and weld quality.

**3. Wells Fargo Sticks to Its Sell Rating for Illinois Tool Works (ITW)**
- Source: The Globe and Mail | 20251216T140833 | Bearish | Relevance: 100%
- Wells Fargo analyst Joe O’Dea maintained a Sell rating on Illinois Tool Works (ITW) with a price target of $245.00, despite the company reporting increased quarterly revenue. The analyst consensus for ITW is currently a Hold with an average price target of $261.00. Insider sentiment for ITW is positive, with recent insider stock purchases noted.

**4. Wells Fargo Sticks to Its Sell Rating for Illinois Tool Works (ITW)**
- Source: The Globe and Mail | 20251216T140831 | Somewhat-Bearish | Relevance: 100%
- Wells Fargo analyst Joe O’Dea maintained a Sell rating on Illinois Tool Works (ITW) with a price target of $245.00, despite the company reporting quarterly revenue of $4.06 billion and a net profit of $821 million. Corporate insider sentiment for ITW is positive, with increased insider buying activity, including a recent significant purchase by Director David Byron Smith. The analyst consensus on ITW is currently a Hold with an average price target of $261.00.

**5. This Illinois Tool Works Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday**
- Source: Benzinga | 20251216T121934 | Bearish | Relevance: 100%
- Several top Wall Street analysts have downgraded the ratings of five major companies. Illinois Tool Works (NYSE: ITW) was downgraded from Neutral to Sell by Goldman Sachs, with a price target cut to $230. Other firms like Gitlab, Zimmer Biomet, StubHub Holdings, and Atmos Energy also saw their ratings lowered by various analysts.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Goldman Sachs | $230 | $258 | -11% |
| 2025-11-18 | B of A Securiti | $255 | $220 | +16% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Goldman Sachs | down | Sell |
| 2025-11-18 | B of A Securiti | up | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 3 ($0.11M) |
| Sells | 3 ($0.37M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.8% |
| Smart Money | **NEUTRAL** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 6 |

**Top Holders:**
- Vanguard Group Inc: 9.2% (-0.1%)
- Briar Hall Managemen: 8.9% (0.0%)
- State Farm Mutual Au: 7.2% (0.0%)
- Blackrock Inc.: 7.2% (-3.6%)
- State Street Corpora: 4.3% (-0.2%)

### Key Risks

1. Valuation stretched: PEG 3.6x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.56 signals overvaluation risk, limited margin of safety. Forward P/E 22.2x stretched relative to 8% growth. Quality metrics strong (ROE 92%, ROA 16%, margin 19%).

| Metric | Value |
|--------|-------|
| Market Cap | $73.2B |
| Beta | 1.15 |
| 52W Range | $214.66 - $278.13 |
| Short Interest | 2.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.56 |
| Forward P/E | 22.2 |
| Current P/E | 24.0 |
| YoY Growth | 8.1% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 4.1% to 0.7% (-3.4% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.3pp (needs >3.0% for momentum thesis). MRS_5 (-1.2%) diverging from MRS_10 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 52. OFD pattern: -SUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.67% (CS: 45) | Neutral |
| RSI_14 | 51.7 | Neutral |
| MACD Histogram | 0.32 | Bullish |
| vs SMA20 | 1.005x | Above |
| vs SMA50 | 1.014x | Above |
| vs SMA200 | 1.001x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $251.18
- **Stop Loss:** $242.66 (3.4% risk)
- **Target:** $259.70 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 83
- **Position Value:** $20,847.94
- **Portfolio %:** 20.85%
- **Risk Dollars:** $712.50
- **Risk Per Trade:** 0.71%
- **Modifiers:** L1 95% | L2 75% | Combined 0.71x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with cautious positioning ahead of CPI data. VIX at moderate 16.87 with positive yield curve suggesting stable growth, but narrow breadth at 51.8% indicates selective participation. Banking sector optimism and corporate resilience provide support, though AI volatility creates pockets of uncertainty.*

### Earnings

**Next:** 2026-02-04 (Est: $2.69)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.70 | $2.81 | +4.0% |
| 2025Q2 | $2.57 | $2.58 | +0.5% |
| 2025Q1 | $2.35 | $2.38 | +1.1% |
| 2024Q4 | $2.49 | $2.54 | +1.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*